August 15, 2025 • 8:55 AM EDT ASP Isotopes Inc. and its Subsidiary, Quantum Leap Energy LLC, enter into a Memorandum of Understanding with Fermi America Regarding a Joint Venture to Collaborate on the Research, Development and Construction of an Advanced Nuclear Fuel Research and Production Facility at the Planned 11GW HyperGrid Campus in Carson County, Texas
August 8, 2025 • 9:00 AM EDT ASP Isotopes Inc. Announces Expected Commencement of Dual Listing on Johannesburg Stock Exchange
July 28, 2025 • 8:31 AM EDT ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment
July 25, 2025 • 8:59 AM EDT Competition Commission of South Africa Approves the Offer by ASP Isotopes Inc. for Renergen Limited
July 23, 2025 • 6:15 PM EDT ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock
July 17, 2025 • 8:00 AM EDT ASP Isotopes Inc. Announces Updates on the Progress of Commercial Production at its Three Enrichment Facilities in South Africa
July 11, 2025 • 8:00 AM EDT Shareholders of Renergen Limited Approve Proposed Acquisition by ASP Isotopes Inc.
June 11, 2025 • 8:23 AM EDT ASP Isotopes Inc. Enhances the Quantum Leap Energy LLC (QLE) Executive Leadership Team with the Appointment of Ryno Pretorius as Chief Executive Officer of QLE
June 4, 2025 • 9:00 AM EDT ASP Isotopes Inc. to host Investor Access Event in South Africa from June 16-18, 2025
June 4, 2025 • 8:30 AM EDT ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies
